Inflammation and vascular permeability correlate with growth in sporadic vestibular schwannoma
-
- Daniel Lewis
- Manchester Centre for Clinical Neurosciences, Salford Royal NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK
-
- Federico Roncaroli
- Manchester Centre for Clinical Neurosciences, Salford Royal NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK
-
- Erjon Agushi
- Manchester Centre for Clinical Neurosciences, Salford Royal NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK
-
- Dominic Mosses
- Division of Neuroscience and Experimental Psychology, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK
-
- Ricky Williams
- Brain Tumour Biobank, Salford Royal NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK
-
- Ka-loh Li
- Wolfson Molecular Imaging Centre, Division of Informatics, Imaging and Data Sciences, University of Manchester, Manchester, UK
-
- Xiaoping Zhu
- Wolfson Molecular Imaging Centre, Division of Informatics, Imaging and Data Sciences, University of Manchester, Manchester, UK
-
- Rainer Hinz
- Wolfson Molecular Imaging Centre, Division of Informatics, Imaging and Data Sciences, University of Manchester, Manchester, UK
-
- Ross Atkinson
- Manchester Centre for Clinical Neurosciences, Salford Royal NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK
-
- Andrea Wadeson
- Manchester Skull Base Unit, Manchester Centre for Clinical Neurosciences, Salford Royal NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK
-
- Sharon Hulme
- Manchester Centre for Clinical Neurosciences, Salford Royal NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK
-
- Helen Mayers
- Department of Cellular Pathology, Salford Royal NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK
-
- Emma Stapleton
- Manchester Skull Base Unit, Manchester Centre for Clinical Neurosciences, Salford Royal NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK
-
- Simon K L Lloyd
- Manchester Skull Base Unit, Manchester Centre for Clinical Neurosciences, Salford Royal NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK
-
- Simon R Freeman
- Manchester Skull Base Unit, Manchester Centre for Clinical Neurosciences, Salford Royal NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK
-
- Scott A Rutherford
- Manchester Skull Base Unit, Manchester Centre for Clinical Neurosciences, Salford Royal NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK
-
- Charlotte Hammerbeck-Ward
- Manchester Skull Base Unit, Manchester Centre for Clinical Neurosciences, Salford Royal NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK
-
- D Gareth Evans
- Manchester Centre for Genomic Medicine, St Mary’s Hospital, Manchester University Hospitals National Health Service Foundation Trust and Manchester Academic Health Science Centre, Manchester, UK
-
- Omar Pathmanaban
- Manchester Skull Base Unit, Manchester Centre for Clinical Neurosciences, Salford Royal NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK
-
- Alan Jackson
- Wolfson Molecular Imaging Centre, Division of Informatics, Imaging and Data Sciences, University of Manchester, Manchester, UK
-
- Andrew T King
- Manchester Centre for Clinical Neurosciences, Salford Royal NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK
-
- David J Coope
- Manchester Centre for Clinical Neurosciences, Salford Royal NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK
収録刊行物
-
- Neuro-Oncology
-
Neuro-Oncology 21 (3), 314-325, 2018-11-02
Oxford University Press (OUP)
